NOV-002
NOV002- IS21 -OC
Phase 2 small_molecule completed
Quick answer
NOV-002 for Ovarian Cancer is a Phase 2 program (small_molecule) at Cellectar Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cellectar Biosciences
- Indication
- Ovarian Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed